期刊文献+

2型糖尿病肾功能减退对血浆脑钠肽质量浓度的影响 被引量:5

Effects of diabetic nephropathy on plasma brain natriuretic peptide levels
原文传递
导出
摘要 目的研究2型糖尿病患者肾功能减退对血浆脑钠肽(BNP)质量浓度的影响。方法2005年2—7月,对重庆医科大学附属第一医院77例2型糖尿病患者血浆BNP质量浓度及BNP的可疑影响因素(包括年龄、性别、血压、体重指数、糖化血红蛋白、血脂、肾功能等)进行测定。结果肾功能正常组[内生肌酐清除率(Ccr)≥1.5mL/s]、肾功能轻度减退组(1.0mL/s≤Ccr〈1.5mL/s)和肾功能重度减退组(Ccr〈1.0mL/s)患者血浆BNP质量浓度差异有显著性意义[(6.7±8.5)ng/L,(13.2±13.1)ng/L,(62.7±71.6)ng/L,P〈0.05];大量蛋白尿组[尿白蛋白排除率(UAER)≥300mg/d]、微量蛋白尿组(30mg/d≤UAER〈300mg/d)和极微量蛋白尿组(UAER〈30mg/d)患者血浆BNP质量浓度差异也具有显著性意义[(110.6±87.1)ng/L,(15.3±14.2)ng/L,(10.8±14.0)ng/L,P〈0.05]。结论肾功能下降可引起2型糖尿病患者血浆BNP质量浓度升高。 Objective To study effects of diabetic nephropathy on plasma brain natriuretic peptide levels in type 2 diabetic patients. Methods Serum BNP levels and suspected influential factors (including age, sex, blood pressure, body mass index, HbA1c,blood lipid, renal function) were investigated in 77 patients with type 2 diabetes mellitus. Results Serum BNP was significantly different [ (6. 7 ± 8. 5 ) ng/L, ( 13. 2± 13. 1 ) ng/L, (62. 7 ± 71.6) ng/L, P 〈 0. 05 ] among renal normal-function group( Ccr≤ 1.5 mL/s)and renal mildly abnormal-function group( 1.0 mL/s ≤ Ccr 〈 1.5 mL/s)and renal markedly abnormal-function group ( Ccr 〈 1.0 mL/s) ; serum BNP was also different [ ( 110. 6 ± 87. 1 ) ng/L, ( 15.3 ± lg. 2 ) ng/L, ( 10. 8 ± 14. 0) ng/L, P 〈 0. 05 ] among macroalbuminuric group( UAER ≥300 mg/d) and microalbuminuric group(30mg/d≤UAER 〈300 mg/d)and normalbuminuric group(UAER 〈30 mg/d). Conclusion Renal dysfunction can raise serum BNP levels in type 2 diabetic patients.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2007年第7期516-518,共3页 Chinese Journal of Practical Internal Medicine
关键词 糖尿病 非胰岛素依赖型 脑钠肽 糖尿病肾病 Diabetes mellitus, non-insulin-dependent Brain natriuretic peptide Diabetic nephropathies
  • 相关文献

参考文献9

  • 1陈雯艾,苗莉,夏颂.脑利钠肽水平对慢性左室收缩性心功能不全程度的诊断价值[J].中国实用内科杂志,2003,23(11):689-689. 被引量:2
  • 2Epshteyn V,Morrison K,Kazanegra R,et al.Utility of B-type natriuretic peptide(BNP) as a screen for left ventricular dysfunction in patients with diabetes[J].Diabetes Care,2003,26:2081-2087.
  • 3Ogawa S,Takeuchi K,Ito S.Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone[J].J Clin Endocrinol Metab,2003,88:3993-3996.
  • 4Bhalla MA,Chiang A,Epshteyn VA,et al.Prognostic role of Btype natriuretic peptide levels in patients with type 2 diabetes mellitus[J].J Am Coll Cardio1,2004,44:1047-1052.
  • 5Liu C,G eorges A,Corcuff JB,et al.B-type natriuretic peptide in diabetes mellitus:the influence of chronic renal failure and meal[J].Diabetes Care,2005,28:752.
  • 6Igarashi M,Jimbu Y,Hirata A,et al.Characterization of plasma brain natriuretic peptide level in patients with type 2 diabetes[J].Endocr J,2005,52:353-362.
  • 7Sarzani R,Dessi-Fulgheri P,Paci VM,et al.Expression of natriuretic peptide receptors in human adipose and other tissues[J].J Endocrinol Invest,1996,19 (9):581-585.
  • 8Weidmann P,Hasler L,Gnadinger MP,et al.Blood levels and renal effects of atrial natriuretic peptide in normal man[J].J Clin Invest,1986,77:734 -742.
  • 9Mckenna K,Smith D,Moore K,et al.Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in type 1 diabetes mellitus[J].Diabet Med,2001,18:973 -978.

二级参考文献5

  • 1Sudoh T, Kangawa K, Minamina N, et al. A new natriuretic peptide in porcine brain. Nature,1988,332:78.
  • 2Mukoyama M, Nakao K, Hosada K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest,1991,87:1402.
  • 3Yandle TG. Biochemistry of natriuretic peptides. J Intern Meal,1994,235(6) :561.
  • 4Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid ,point-of-care test for screening patients undergoing echocardioraphy to determine left ventricular dysfunction. Am Heart J,2001,141:367.
  • 5Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J,2001,22 : 1527.

共引文献1

同被引文献71

  • 1徐倩,商永芳,袁鹰,苗志敏.脑利尿钠肽与早期糖尿病肾病的关系[J].齐鲁医学杂志,2006,21(2):144-145. 被引量:3
  • 2黄群,杨香玖,姚弘,张岩,黄延玲.血清胱抑素C在2型糖尿病不同肾损害期的变化及其临床意义[J].临床内科杂志,2006,23(7):476-477. 被引量:36
  • 3何玉芸,林凯,黎映兰,邓海鸥.糖尿病肾病患者血清脑利尿钠肽水平及其意义[J].广东医学,2007,28(3):431-432. 被引量:6
  • 4Sodoh T,Kangawa K,minamion N,et al.A natriuretic peptide in porcine brain.Nature,1988,322:78-81.
  • 5Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.N Engl J Med,2002,347:161-162.
  • 6Krishnaswamy P,Lubien E,Clopton P,et al.Utility of B-type peptide levels in identifying patients with left ventricular systolic dysfunction.Am J Med,2001,111:274-279.
  • 7Austin PC,Mamdani MM,Jaakkimainen I,et al.Intravenous nosiritide vs nitroglycerin for treatment of decompensated congetive heart failure.A randomized controlled trial.JAMA,2002,287:1531-1540.
  • 8Yancy CW,Saltzberg M,Berkowitz RL.For the FUSION Investigators.Management of patients with congestive heart failure after hospitalization:results from the Follow Up Serial Infusions of Nesiritide(FUSION) trial.Card Fail,2003,9(S5):S232-238.
  • 9Burger A J,Horton DP,Lejemtel T,et al.Effect of natriuretic (B-type natriuretic peptide) and dobuta mine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure the PRECEDENT study.Heart,2002,144:1102-1108.
  • 10Jonathan SB,HalAS,Keith DA,et al.Risk of worsening renal function with nesiritide in patients with acute decompensated heart failure.Circulation,2005,111:1489-1491.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部